Cargando…
Systemic therapy of Cushing’s syndrome
Cushing’s disease (CD) in a stricter sense derives from pathologic adrenocorticotropic hormone (ACTH) secretion usually triggered by micro- or macroadenoma of the pituitary gland. It is, thus, a form of secondary hypercortisolism. In contrast, Cushing’s syndrome (CS) describes the complexity of clin...
Autores principales: | Eckstein, Niels, Haas, Bodo, Hass, Moritz David Sebastian, Pfeifer, Vladlena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237936/ https://www.ncbi.nlm.nih.gov/pubmed/25091295 http://dx.doi.org/10.1186/s13023-014-0122-8 |
Ejemplares similares
Ejemplares similares
-
Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer
por: Eckstein, Niels, et al.
Publicado: (2014) -
Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin
por: Haas, B, et al.
Publicado: (2014) -
Targeting adipose tissue
por: Haas, Bodo, et al.
Publicado: (2012) -
Cushing’s Syndrome Effects on the Thyroid
por: Paragliola, Rosa Maria, et al.
Publicado: (2021) -
Endocrine hypertension – Cushing's syndrome
por: Singh, Yashpal, et al.
Publicado: (2011)